All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma
Authors
Keywords
-
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-18
DOI
10.1007/s00280-020-04172-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aggressive T‐ cell Lymphomas: 2019 updates on diagnosis, risk stratification and management
- (2019) Jasmine M. Zain AMERICAN JOURNAL OF HEMATOLOGY
- The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma
- (2019) M. Christina Cox et al. INVESTIGATIONAL NEW DRUGS
- Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study Group
- (2019) Kitsada Wudhikarn et al. Journal of Geriatric Oncology
- Metronomic combination chemotherapy using everolimus and etoposide for the treatment of non-Hodgkin lymphoma
- (2019) Ke Wu et al. Cancer Medicine
- The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management
- (2019) Enrica Marchi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors
- (2018) Paola Orlandi et al. BIOCHEMICAL PHARMACOLOGY
- Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network
- (2018) Massimo Federico et al. BRITISH JOURNAL OF HAEMATOLOGY
- Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data
- (2018) Gianfranco Natale et al. CANCER LETTERS
- Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience
- (2018) Roland Christian Schelker et al. BMC CANCER
- A prospective cohort study of patients with peripheral T-cell lymphoma in the United States
- (2016) Kenneth R. Carson et al. CANCER
- Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients
- (2016) Teresa Di Desidero et al. INVESTIGATIONAL NEW DRUGS
- Remission of an extensively pre-treated relapsing/refractory ALK-positive anaplastic large cell lymphoma following metronomic therapy
- (2016) Shunzong Yuan et al. LEUKEMIA & LYMPHOMA
- Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect
- (2016) Guido Bocci et al. Nature Reviews Clinical Oncology
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors
- (2013) Vivien Mak et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi
- (2013) Francesco Merli et al. LEUKEMIA & LYMPHOMA
- Continuous oral cyclophosphamide and prednisolone as a valuable treatment option for peripheral T cell lymphoma
- (2010) Alessandra Tucci et al. BRITISH JOURNAL OF HAEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now